Illumina's Q1 Array Revenues Rise 4 Percent on Sales to Ag Research, Reproductive Health Customers | GenomeWeb

NEW YORK (GenomeWeb) — Microarray sales to agricultural and cancer researchers as well as reproductive health and consumer clients drove Illumina's chip revenues up 4 percent in the first quarter, the company said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.